HomeEXECUTIVES
EXECUTIVES
The medical device news magazine is the latest source for industry scoop. In this article, we take a look at which executives are on the move.
As the medical device industry rapidly expands, so does the need for executive leadership. Recently, several top executives have made moves within the industry. Some have taken new positions at other companies, while others have started their own businesses. Here’s a look at who’s been making headlines lately.
Ronil Patel Appointed Chief Business Officer at RevOpsis Therapeutics
Ronil Patel currently serves as a strategic advisor to Collage Venture Partners and was previously the Chief Business Officer at Ocuphire Pharma, a publicly traded ophthalmology biotechnology company. Prior to Ocuphire, Patel led business development for Point Guard Partners and Oculos Clinical Research (now iuvo Bioscience). Patel has been instrumental in biotech research and development and global business expansion. He has also contributed to teams that have secured approximately $100 million in funding and finalized licensing and exit deals valued at over $500 million.
Julie Sawyer Montgomery | Appointed Executive Vice President for Diagnostics at Danaher Corporation
Julie Sawyer Montgomery currently Vice President and Group Executive of Danaher's Clinical Diagnostics businesses, will become an executive officer of Danaher reporting to the President and Chief Executive Officer, Rainer Blair.
Mark Eisner MD, M.P.H. Appointed Chief Medical Officer at Vir Biotechnology
Mark Eisner MD comes from Sonoma Biotherapeutics, Inc., where he most recently held the position of CMO. In this role, he led all development functions which included biometrics, regulatory, clinical science, clinical operations, drug safety, and pharmacology.
Franck Mevellec Appointed Senior Director, Business Development at Asymchem
Franck Mevellec boasts a proven track record of success, having held key positions at industry leaders like Bayer Healthcare (R&D), Teva Pharmaceuticals (portfolio director), Minakem (BD director), and most recently, Seqens (global head of sales). He joins Asymchem with a focus on expanding the company’s footprint across Europe.
Veristat Appoints Dr Gabriela Rosu to Lead Growing Medical Affairs Team
Dr Gabriela Rosu is a seasoned professional with over twenty years of experience in scientific and clinical fields, having significantly contributed to the planning and execution of pivotal activities that have led to the approval and commercialization of groundbreaking therapies.
Sphere Fluidics Appoints Curtis Nicholson as Director of Sales, EMEA, to Support Accelerated Growth in Key Markets
Curtis Nicholson said “I’m thrilled to leverage my experience in strategic sales and driving innovation to take on this exciting role at Sphere Fluidics. I look forward to collaborating with the talented team and accelerating the adoption of our transformative solutions.”
Fiona Coats Appointed Chief Marketing Officer at Refeyn
Fiona Coats will bring with her a wealth of experience from over 25 years in the biotechnology sector. Her extensive background in science, combined with a proven track record of driving growth and innovation, positions her as a respected leader in the life science research market.
Simona Skerjanec Appointed to the BOD at Avidity Biosciences
Simona Skerjanec has led multiple research and development efforts that have resulted in regulatory approvals and launches of commercial therapies in therapeutic areas including neurology and cardiology in the U.S. and other countries.
Patrick Clysdale Joins Direct Sales Team at Herculite Products
Patrick Clysdale Patrick Clysdale will manage the company's Direct Sales team's southeastern region, which includes automotive, custom-engineered solutions, healthcare, agriculture, and tent and structure customers.
Dr Cheryl Pegus Elected to the Boston Scientific Board of Directors
Dr Cheryl Pegus has more than 25 years of clinical and business leadership experience, most recently serving as a partner at Morgan Health focused on improving the quality, affordability and equity of health care.
Recent News
MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES
Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants
"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."
MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES
Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting
This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.
MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES
Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution
“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”